(Q78550526)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12443835%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

title

The role of treatment intentions and concerns about side effects in women's decision to discontinue postmenopausal hormone therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12443835%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

author name string

Robert F Reynolds

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12443835%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Carla Makhlouf Obermeyer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12443835%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Alexander M Walker

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12443835%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Daniel Guilbert

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12443835%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

publication date

1 November 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12443835%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12443835%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12443835%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12443835%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

183-194

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12443835%20AND%20SRC:MED&resulttype=core&format=json

Hormone therapy to prevent disease and prolong life in postmenopausal women

15 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Lung cancer and indoor air pollution arising from Chinese-style cooking among nonsmoking women living in Shanghai, China

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Hormone replacement therapy and peripheral arterial disease: the Rotterdam study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Effects of hormone replacement therapy on hemostatic cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Risk of venous thromboembolism in users of hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Prospective study of exogenous hormones and risk of pulmonary embolism in women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Decision-making and hormone replacement therapy: a qualitative analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Women's beliefs and decisions about hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

The prevalence of oestrogen replacement therapy in South Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

What women want from hormone replacement therapy: results of an international survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Compliance with hormone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Compliance with hormonal replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Compliance considerations with estrogen replacement: withdrawal bleeding and other factors

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Risk factors associated with women's compliance with estrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Discontinuation of postmenopausal hormone therapy in a Massachusetts HMO.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Side effects and sociobehavioral factors associated with the discontinuation of hormone therapy in a Massachusetts health maintenance organization.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Prevalence of and factors associated with hormone replacement therapy counseling: results from the 1994 National Health Interview Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

The North American Menopause Society 1998 menopause survey: Part II. Counseling about hormone replacement therapy: association with socioeconomic status and access to medical care.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

The physician's role in women's decision making about hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

Perception of future health risks in mid-aged women: estimates with and without behavioural changes and hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

A comparison of responses to mailed questionnaires and telephone interviews in a mixed mode health survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900204-9

7 January 2021

10.1016/S0378-5122(02)00204-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12443835%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference